Form 4: AIM ImmunoTech Director Nancy Bryan Acquires Shares in Lieu of Cash Compensation

Director Nancy Bryan acquired 25,797 shares of AIM ImmunoTech Inc. common stock on January 31, 2025, in lieu of cash compensation under the company's Cash Conservation Plan.

Summary

• On January 31, 2025, Nancy Bryan, a director of AIM ImmunoTech Inc., acquired 25,797 shares of common stock.
• The shares were acquired at a price of $0.2019 per share.
• This acquisition was made in lieu of director compensation, as part of the company's Cash Conservation Plan.
• Following the transaction, Bryan directly owns 165,073 shares of AIM ImmunoTech Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine disclosure of a director's share acquisition as part of a compensation plan. The Cash Conservation Plan could be seen as slightly positive, indicating prudent financial management, but it could also raise questions about the company's cash position.

Positives

• The acquisition demonstrates the director's confidence in the company, as they are willing to accept shares in lieu of cash.
• The Cash Conservation Plan helps the company manage its cash flow.

Industry Context

Directors often receive stock options or shares as part of their compensation packages. This is a common practice to align the interests of the directors with those of the shareholders. The use of a Cash Conservation Plan suggests the company is focused on managing its cash resources, which can be a common strategy for companies in the biotechnology sector, especially during development phases.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholders, as it aligns the director's interests with theirs.
• The Cash Conservation Plan may impact employees if it leads to changes in compensation or benefits.

Key Dates

Keywords

AIM ImmunoTech, Nancy Bryan, director, share acquisition, Form 4, Cash Conservation Plan, common stock, compensation